A Trial of a Transglutaminase 2 Inhibitor in Celiac Disease. Reply

N Engl J Med. 2021 Oct 14;385(16):e57. doi: 10.1056/NEJMc2112688.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Celiac Disease* / drug therapy
  • GTP-Binding Proteins
  • Humans
  • Transglutaminases

Substances

  • transglutaminase 2
  • Transglutaminases
  • GTP-Binding Proteins